GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Cash, Cash Equivalents, Marketable Securities

J.Molner AS (OTSE:MOLNR) Cash, Cash Equivalents, Marketable Securities : €0.09 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Cash, Cash Equivalents, Marketable Securities?

J.Molner AS's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 (€0.72 Mil) to Jun. 2023 (€0.68 Mil) but then stayed the same from Jun. 2023 (€0.68 Mil) to Dec. 2023 (€0.09 Mil).

J.Molner AS's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (€0.24 Mil) to Dec. 2022 (€0.72 Mil) but then declined from Dec. 2022 (€0.72 Mil) to Dec. 2023 (€0.09 Mil).


J.Molner AS Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for J.Molner AS's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Cash, Cash Equivalents, Marketable Securities Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
0.24 0.72 0.09

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Cash, Cash Equivalents, Marketable Securities 0.24 0.31 0.72 0.68 0.09

J.Molner AS Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


J.Molner AS  (OTSE:MOLNR) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


J.Molner AS Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines